Cyclerion Therapeutics, Inc. (CYCN) › Operating Cash FlowCyclerion Therapeutics, Inc. (CYCN) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2018: -$97.50M2019: -$102.22M2020: -$72.49M2021: -$36.52M2022: -$40.61M2023: -$21.25M2024: -$4.33M2025: -$3.31M-$3.31M2018Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$3.31M+23.5%2024-$4.33M+79.6%2023-$21.25M+47.7%2022-$40.61M-11.2%2021-$36.52M+49.6%2020-$72.49M+29.1%2019-$102.22M-4.8%2018-$97.50M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share